| | Identification | Back Directory |  | [Name] 
 FMOC-ALPHA-ME-LEU-OH
 |  | [CAS] 
 312624-65-0
 |  | [Synonyms] 
 Fmoc-a-Me-Leu-OH
 Fmoc-α-Me-Leu-OH
 Fmoc-2-Me-L-Leu-OH
 Fmoc-α-Me-L-Leucine
 FMOC-ALFA-ME-LEU-OH
 FMOC-ALPHA-ME-LEU-OH
 FMoc-alphaMe-L-Leu-OH
 Fmoc-alpha-Me-L-Leucine
 Fmoc-α-methyl-L-Leucine
 N-Fmoc-a-Methyl-L-leucine
 (S)-N-Fmoc-A-Methylleucine
 (S)-N-FMOC-Α-METHYLLEUCINE
 Fmoc-alpha-methyl-L-leucine
 (S)-N-Fmoc-α-Methylleucine, >97%
 FMOC-(S)-2-amino-2,4-dimethylpentanoicacid
 (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2
 N-α-(9-Fluorenylmethoxycarbonyl)-α-methyl-L-leucine
 (2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2
 (9H-Fluoren-9-yl)MethOxy]Carbonyl Alpha-Methyl-Leu-OH
 L-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-
 (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,4-dimethylpentanoic acid
 (2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,4-dimethylpentanoic acid
 |  | [Molecular Formula] 
 C22H25NO4
 |  | [MDL Number] 
 MFCD08458572
 |  | [MOL File] 
 312624-65-0.mol
 |  | [Molecular Weight] 
 367.44
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 562.7±33.0 °C(Predicted)
 |  | [density ] 
 1.189±0.06 g/cm3(Predicted)
 |  | [storage temp. ] 
 Sealed in dry,Room Temperature
 |  | [form ] 
 powder
 |  | [pka] 
 3.95±0.41(Predicted)
 |  | [color ] 
 white
 |  | [InChI] 
 InChI=1S/C22H25NO4/c1-14(2)12-22(3,20(24)25)23-21(26)27-13-19-17-10-6-4-8-15(17)16-9-5-7-11-18(16)19/h4-11,14,19H,12-13H2,1-3H3,(H,23,26)(H,24,25)/t22-/m0/s1
 |  | [InChIKey] 
 LKQDQIGTIVQHMG-QFIPXVFZSA-N
 |  | [SMILES] 
 C(O)(=O)[C@](C)(CC(C)C)NC(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)=O
 | 
 | Hazard Information | Back Directory |  | [Chemical Properties] 
 White powder
 |  | [Uses] 
 Fmoc-α-Me-Leu-OH is a leucine derivative with an Fmoc protecting group, which can be used to synthesize peptides with oxytocin receptor agonist activity[1].
 |  | [References] 
 [1] Caterina Bissantz, et al. Peptides as oxytocin agonists. WO2015185584A1. 2015-06-03
 | 
 |  |